Protara Therapeutics, Inc. Share Price & Technical Analysis
TARA · $4.92 (-1.01%)
Healthcare / Biotechnology
$4.92
-1.01%
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline…
Price chart
Seasonality
May has 0 positive and 5 negative years (last 5 years shown)
-8% return in May, -12% avg return in past 3 year May month.
-1% return in 2026, 60% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 31% | -10% | -17% | 2% | -8% | – | – | – | – | – | – | – | -1% |
| 25 | -8% | -20% | 13% | -17% | -17% | -3% | 0% | 3% | 39% | 18% | 40% | -27% | 22% |
| 24 | 32% | 84% | -13% | -27% | -7% | -25% | 5% | -9% | -10% | 39% | 20% | 77% | 165% |
| 23 | 27% | 6% | -14% | 3% | -12% | -14% | 8% | -15% | -23% | -25% | 15% | 36% | -8% |
| 22 | -24% | -13% | 9% | -29% | -8% | -12% | 3% | 17% | -14% | 3% | 13% | -29% | -84% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$280.53M
P/E ratio
—
52W high
$7.82
52W low
$2.77
Volume
11,30,340
Beta
1.52
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Protara Therapeutics, Inc. share price today?
- Protara Therapeutics, Inc. (TARA) last traded around $4.92 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does TARA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TARA. Download the app for real-time alerts.
- How can I analyze Protara Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.